Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 6/20 | 0.56 |
| ▸ | DRD2 | P14416 | 6/20 | 0.56 |
| ▸ | ADRA2B | P18089 | 6/20 | 0.56 |
| ▸ | ADRA2C | P18825 | 6/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.56 |
| ▸ | HTR2A | P28223 | 6/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 6/20 | 0.56 |
| ▸ | HRH1 | P35367 | 6/20 | 0.56 |
| ▸ | DRD3 | P35462 | 6/20 | 0.56 |
| ▸ | HTR2B | P41595 | 6/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 5/20 | 0.56 |
| ▸ | DRD1 | P21728 | 4/20 | 0.56 |
| ▸ | MLNR | O43193 | 2/20 | 0.56 |
| ▸ | ESR1 | P03372 | 2/20 | 0.56 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | KDM1A | O60341 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10136955 | 0.93 | DRD2 (0.55) | HTR1ADRD2ADRA2BADRA2CSLC6A2 | |
| SCHEMBL10136857 | 0.89 | KDM1A (0.61) | HTR1ADRD2ADRA2BADRA2CSLC6A2 | |
| SCHEMBL560413 | 0.88 | KIF11 (0.71) | HTR1ADRD2ADRA2BADRA2CSLC6A2 | |
| SCHEMBL12715985 | 0.87 | HRH1 (0.56) | HTR1ADRD2ADRA2BADRA2CSLC6A2 | |
| SCHEMBL10136856 | 0.86 | DRD2 (0.56) | HTR1ADRD2ADRA2BADRA2CSLC6A2 | |
| SCHEMBL10136880 | 0.83 | KDM1A (0.54) | HTR1ADRD2ADRA2BADRA2CSLC6A2 | |
| SCHEMBL10136951 | 0.83 | HTR1A (0.52) | HTR1ADRD2ADRA2BADRA2CSLC6A2 | |
| SCHEMBL10136925 | 0.82 | DRD3 (0.60) | HTR1ADRD2ADRA2BADRA2CSLC6A2 | |
| SCHEMBL10136832 | 0.82 | KDM1A (0.52) | HTR1ADRD2ADRA2BADRA2CSLC6A2 | |
| SCHEMBL560511 | 0.81 | KIF11 (0.70) | HTR1ADRD2ADRA2BADRA2CSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120035161-A1 | Novel Compositions and Methods of Treating Diseases Using the Same | CORRIDOR PHARMACEUTICALS, INC. | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035161-A1 | Novel Compositions and Methods of Treating Diseases Using the Same | NFATC1, BAX, BCL2 | HTR1A 3332/4885DRD2 4807/4885ADRA2B 2267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.